RxDoctor Payments Data

Gina Toth, NP

Family · Saint Clairsville, OHNPI 1093174427

Payments from drug & device makers

$1,502in general payments, 2019–2025

Across 88 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$329
  • Abbott$249
  • Lilly USA, LLC$232
  • Dexcom, Inc.$167
  • Exact Sciences$107
  • Boehringer Ingelheim$90
  • plus $328 from 9 others

What the payments were for

  • Food & beverage$1,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,502 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$47,744
Medicare patients
197
Services billed
1,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide138$164,680
JardianceEmpagliflozin81$78,211
JanuviaSitagliptin Phosphate38$39,781
TrulicityDulaglutide33$36,617
FarxigaDapagliflozin Propanediol29$20,964
TradjentaLinagliptin21$20,770
EliquisApixaban18$17,688
LinzessLinaclotide28$17,402
SymbicortBudesonide/Formoterol Fumarate16$8,048
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$6,200
Advair HfaFluticasone Propion/Salmeterol18$5,779
Levothyroxine Sodium445$4,040
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,948
Rosuvastatin Calcium293$3,799
Atorvastatin Calcium378$3,227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$329$164,680138 claims
Boehringer IngelheimJardiance, Tradjenta$90$98,981102 claims
Lilly USA, LLCTrulicity$232$36,61733 claims
AstraZenecaFarxiga, Symbicort$27$29,01245 claims
PfizerEliquis$66$17,68818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Saint Clairsville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →